California-based AI-drug discovery company Deepcell and NVIDIA have entered a research partnership to advance the use of GenAI-powered cellular analysis in life sciences.
As part of the partnership, Deepcell plans to integrate NVIDIA's AI into its single-cell analysis technology and co-develop new uses for GenAI and multimodal applications in cell biology. Additionally, the collaboration will leverage NVIDIA's computing capabilities and the Clara suite to develop advanced algorithms for cell imagery analysis.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.